Amanote Research

Amanote Research

    RegisterSign In

Management of Overactive Bladder

doi 10.1007/978-3-319-98720-0_97
Full Text
Open PDF
Abstract

Available in full text

Date

November 3, 2018

Authors
Sanchia S. GoonewardenePeter PietrzakDavid Albala
Publisher

Springer International Publishing


Related search

Transdermal Oxybutynin: What Role in the Management of Overactive Bladder?

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

Oxybutynin Extended Release for the Management of Overactive Bladder: A Clinical Review

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2009English

Overactive Bladder: Symptom or Syndrome?

BJU International
Urology
2003English

New Developments in the Management of Overactive Bladder: Focus on Mirabegron and onabotulinumtoxinA

Therapeutics and Clinical Risk Management
2013English

Refractory Overactive Bladder: A Common Problem?

International Urogynecology Journal
GynecologyUrologyObstetrics
2015English

The Overlap of Interstitial Cystitis/Painful Bladder Syndrome and Overactive Bladder

Journal of the Society of Laparoendoscopic Surgeons
Surgery
2010English

Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome

Frontiers in Neuroscience
Neuroscience
2018English

OnabotulinumtoxinA for the Treatment of Overactive Bladder

Research and Reports in Urology
Urology
2014English

Affective Temperament Profiles of Overactive Bladder Patients

Noropsikiyatri Arsivi
PsychiatryNeuroscienceMental Health
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy